Professor Arthur Sun Myint
F.R.C.P (Edin); F.R.C.P. (London); F.F.R.C.S. (Dublin): F.R.C.R; F.I.C.S. (Chicago)
Lead Clinician (Papillon), Clatterbridge Cancer Centre. Liverpool, UK.
Vice President, International Contact Radiotherapy Society (ICONE), Nice.
Past chairman, GEC ESTRO rectal & anal brachytherapy sub group, Brussels
Expert (Brachytherapy), International Atomic Energy Agency (IAEA), Vienna
Specialist advisor (rectal brachytherapy) NICE, UK
Hon. Clinical Professor, Molecular and Clinical cancer Medicine Dept., University of Liverpool, Liverpool, UK.
Special Advisor in Oncology to Minister of Health & Sports in Myanmar.
Prof. Sun Myint graduated from IM (2) Yangon, Burma in 1972. He was appointed as a Clinical scientist for Medical Research Council’s Neutron trial project in 1983 and chaired the MRC colorectal sub-group for neutron trials until 1995. He was the chair of Tumour Speciality Group (TSG) for Gastrointestinal malignancies at Clatterbridge Centre for Oncology (1998-2012) where he worked as a consultant for over 35 years. His main research interest is in the treatment of rectal cancers. He introduced contact X-ray Brachytherapy (CXB) also known as (Papillon) into the UK and started treating patients at Clatterbridge from 1993. So far, he has treated over 3000 patients using Papillon technique which is the world largest cohort of patients ever treated by this technique. He helped design a new contact X-ray brachytherapy machine Papillon 50 and Papillon Plus together with his mentor Prof Jean Pierre Gerard in collaboration with Ariane (British) and Clerad (French)Companies. He is the director of annual Papillon course at Clatterbridge (2010-present).
He was appointed specialist advisor for NICE for rectal brachytherapy and helped write the guide lines published in Dec 2006, Sept 2015 and August 2019. He was a member of NCRI rectal and anal sub group committees (1995-2012). He has published over 100 peer reviewed publications and an author of 8 text book chapters. He was the guest editor for special issues of Clinical Oncology (Vol 35: Issue 2; Feb 2023 and Vol.19: No 9; Nov, 2007), Colorectal Disease (Vol 12: Supp 2:2010 and Vol 21: Supp 1:2019) on radiotherapy for early rectal cancer, advanced rectal cancer and management of significant polyps (SPECC). He was a guest editor of Clinical Oncology special issue on 'Multi-modality management of early rectal cancer' jointly with his mentor Prof Jean Pierre Gerard (Vol 35 issue2 Feburary 2023 ISSN 0936-6555).
He served as the oncology representative on the Council of Association of Coloproctology from 2006-2009. He was elected on the faculty (2006-2009) then served on the Council of the Royal College of Radiologists (2009-2012). In May 2011, he was appointed by GEC-ESTRO committee to chair the brachytherapy group for rectal and anal cancers (2011-20). He served as the President of International Contact Radiotherapy Society [ICONE] (2013-18). He noe continuer to serve ICONE as the Vice President since 2019. He is the Lead clinician of Papillon Unit at the Clatterbridge Cancer Centre which opened in June 2013. He was appointed as an expert advisor on radiotherapy with IAEA imPACT mission to Myanmar in November 2015 and December 2016. In recognition of his contributions to medicine and oncology he was awarded an Honorary Professor by the University of Liverpool in Dec, 2012. Professor Sun Myint was appointed by H.E. Minister of Health &Sports Dr Myint Htwe as his special advisor for oncology in Myanmar from July 2017. Papillon team led by him won the prestigious BMJ award for ‘Cancer team of the year’ in 2018. Prof Sun Myint and his team at the University of Liverpool won the Horizon 2020 Marie Curie award which supports 2 PhD students to join his team to continue his research projects for 4 years.
ORCID ID: 0000-0001-5323-5696
https://scholar.google.co.uk/citations?hl=en&user=hXYQTq8AAAAJ&view op=list
http://share.ecancer.org/NCRI2016/Arthur%20Sun%20Myint.mp4
https://youtu.be/cZC37LF4y2c